生命科学资讯

In the clinic for Dec. 4, 2025

Other news to note for Dec. 4, 2025

Regulatory actions for Dec. 4, 2025

12 former FDA chiefs blast Prasad’s move to toughen vaccine standards

Trump administration pushes end-of-term deadline for ‘most favored nation’ promises

Tracey Beth Høeg, top Makary deputy, named head of FDA drug office

Bio/Pharmaceutical Outsourcing Report, October 2025 - Pfizer and Roche Place $10 Billion Bets on Obesity and Liver Disease Therapies as Trump Tightens Grip on Drug Pricing and Manufacturing - Yahoo Finance

Looking At Agilent Technologies's Recent Unusual Options Activity - Benzinga

Retraction notice to: Transcriptome-scale RNA-targeting CRISPR screens reveal essential lncRNAs in human cells

Fertilization triggers early proteomic symmetry breaking in mammalian embryos

After dodging Biosecure threat, WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg

Crescent waxes pipeline with $80M Kelun deal, bagging ADC to pair with PD-1xVEGF bispecific

Royalty pens $275M financing deal for Denali drug awaiting delayed FDA decision

After more than 20 years, Medtronic claims deep brain stimulation approval for dystonia

A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes

Thermo Fisher Scientific (TMO): Reassessing Valuation After Recent Share Price Gains - simplywall.st

Transcript : Agilent Technologies, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 09 - MarketScreener

Global insights on scaling and integrating digital health - Roche

UniQure restates FDA's negative feedback on Huntington's trial; Neurimmune's expanded AstraZeneca alliance

BioNexus gets $500M to step into manufacturing; Thermo Fisher, AtomVie expand